These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 24481145)
1. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis. Li X; Kong X; Jiang L; Ma T; Yan S; Yuan C; Yang Q Cell Physiol Biochem; 2014; 33(1):165-72. PubMed ID: 24481145 [TBL] [Abstract][Full Text] [Related]
2. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with ovarian cancer susceptibility. Yan S; Yuan C; Yang Q; Li X; Yang N; Liu X; Dong R; Zhang X; Yuan Z; Zhang N; Kong B Oncol Rep; 2015 Oct; 34(4):2151-5. PubMed ID: 26252839 [TBL] [Abstract][Full Text] [Related]
3. A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy. Tang Q; Zhao Y; Wang Y; Wei M Med Oncol; 2014 Nov; 31(11):267. PubMed ID: 25270285 [TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of calcium-sensing receptor in women with breast cancer. Campos-Verdes LM; da Silva-Sampaio JP; Costa-Silva DR; de Oliveira VA; Junior AMC; Silva VC; Alencar AP; Campelo V; Lopes-Costa PV; Gebrim LH; da Silva BB Med Oncol; 2018 Jan; 35(3):23. PubMed ID: 29387985 [TBL] [Abstract][Full Text] [Related]
5. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis. Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488 [TBL] [Abstract][Full Text] [Related]
6. A genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis. Chou YH; Woon PY; Chen WC; Hsu YW; Chang JM; Hwang DY; Chiu YC; Kuo HC; Chang WP; Hou MF; Liu ME; Chang JG; Chang WC PLoS One; 2011; 6(9):e25227. PubMed ID: 21966463 [TBL] [Abstract][Full Text] [Related]
7. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer. Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278 [TBL] [Abstract][Full Text] [Related]
8. Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians. Rizk SM; Shahin NN; Shaker OG PLoS One; 2016; 11(3):e0151901. PubMed ID: 26999517 [TBL] [Abstract][Full Text] [Related]
9. CASR rs1801725 polymorphism is associated with the risk and prognosis of colorectal cancer: A case-control study. Diao YE; Xu Q J Clin Lab Anal; 2020 Nov; 34(11):e23463. PubMed ID: 32648293 [TBL] [Abstract][Full Text] [Related]
10. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis]. Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778 [TBL] [Abstract][Full Text] [Related]
11. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294 [TBL] [Abstract][Full Text] [Related]
12. Correlations of Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes. Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573 [TBL] [Abstract][Full Text] [Related]
14. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study. Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444 [TBL] [Abstract][Full Text] [Related]
15. Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients. Wang L; Widatalla SE; Whalen DS; Ochieng J; Sakwe AM BMC Cancer; 2017 Aug; 17(1):511. PubMed ID: 28764683 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan. Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279 [TBL] [Abstract][Full Text] [Related]
17. Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study. Al Balawi IA; Mir R; Abu-Duhier FM Asian Pac J Cancer Prev; 2018 Apr; 19(4):1135-1143. PubMed ID: 29699375 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study. Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607 [TBL] [Abstract][Full Text] [Related]
19. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study. Bayram S; Sümbül AT; Dadaş E Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852 [TBL] [Abstract][Full Text] [Related]
20. Genetic variation in calcium-sensing receptor and risk for colon cancer. Dong LM; Ulrich CM; Hsu L; Duggan DJ; Benitez DS; White E; Slattery ML; Caan BJ; Potter JD; Peters U Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2755-65. PubMed ID: 18843020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]